Rein Therapeutics Financial Overview
Rein Therapeutics's market cap is currently $37.33M. The company's EPS TTM is $-0.21; its P/E ratio is -0.54; Rein Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
